Showing 1 - 13 results of 13 for search 'Ninna Aggerholm-Pedersen', query time: 0.04s Refine Results
  1. 1
    Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients

    Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients by Anne Winther-Larsen, Ninna Aggerholm-Pedersen, Birgitte Sandfeld-Paulsen

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis

    Inflammation scores as prognostic biomarkers in small cell lung cancer: a systematic review and meta-analysis by Anne Winther-Larsen, Ninna Aggerholm-Pedersen, Birgitte Sandfeld-Paulsen

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Pretreatment Albumin-to-Alkaline Phosphatase Ratio Is a Prognostic Marker in Lung Cancer Patients: A Registry-Based Study of 7077 Lung Cancer Patients

    Pretreatment Albumin-to-Alkaline Phosphatase Ratio Is a Prognostic Marker in Lung Cancer Patients: A Registry-Based Study of 7077 Lung Cancer Patients by Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Anne Winther-Larsen

    Published 2021-12-01
    Get full text
    Article
  4. 4
    Risk factors for recurrent disease after resection of solitary fibrous tumor: a systematic review

    Risk factors for recurrent disease after resection of solitary fibrous tumor: a systematic review by Johan Tolstrup, Anand Loya, Ninna Aggerholm-Pedersen, Louise Preisler, Luit Penninga

    Published 2024-01-01
    Get full text
    Article
  5. 5
    A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice

    A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice by Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Mie Hessellund Samson, Holger Jon Møller

    Published 2022-06-01
    Get full text
    Article
  6. 6
    The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma

    The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma by Ninna Aggerholm-Pedersen, Katja Maretty-Kongstad, Johnny Keller, Steen Baerentzen, Akmal Safwat

    Published 2016-08-01
    Get full text
    Article
  7. 7
    Targeted Treatment of Soft-Tissue Sarcoma

    Targeted Treatment of Soft-Tissue Sarcoma by Anne Iren Riskjell, Vivi-Nelli Mäkinen, Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen

    Published 2023-04-01
    Get full text
    Article
  8. 8
    Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients

    Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients by Ninna Aggerholm-Pedersen, Henriette Nymark Friis, Thomas Baad-Hansen, Holger Jon Møller, Birgitte Sandfeld-Paulsen

    Published 2023-02-01
    Get full text
    Article
  9. 9
    The Importance of Reference Gene Analysis of Formalin-Fixed, Paraffin-Embedded Samples from Sarcoma Patients — An Often Underestimated Problem

    The Importance of Reference Gene Analysis of Formalin-Fixed, Paraffin-Embedded Samples from Sarcoma Patients — An Often Underestimated Problem by Ninna Aggerholm-Pedersen, Akmal Safwat, Steen Bærentzen, Marianne Nordsmark, Ole Steen Nielsen, Jan Alsner, Brita S. Sørensen

    Published 2014-12-01
    Get full text
    Article
  10. 10
    Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value

    Inclusion of Metabolic Tumor Volume in Prognostic Models of Bone and Soft Tissue Sarcoma Increases the Prognostic Value by Mette Abildgaard Pedersen, Thomas Baad-Hansen, Lars C. Gormsen, Steen Bærentzen, Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Mikkel Holm Vendelbo

    Published 2023-01-01
    Get full text
    Article
  11. 11
    Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors

    Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors by Jesper Geert Pedersen, Anne Tranberg Madsen, Kristine Raaby Gammelgaard, Ninna Aggerholm-Pedersen, Boe Sandahl Sørensen, Trine Heide Øllegaard, Martin Roelsgaard Jakobsen

    Published 2020-05-01
    Get full text
    Article
  12. 12
    Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma

    Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma by Jesper Geert Pedersen, Mateo Sokac, Boe Sandahl Sørensen, Adam Andrzej Luczak, Ninna Aggerholm-Pedersen, Nicolai Juul Birkbak, Trine Heide Øllegaard, Martin Roelsgaard Jakobsen

    Published 2022-07-01
    Get full text
    Article
  13. 13
    The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor

    The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor by Charlotte Margareta Brinch, Estrid Hogdall, Niels Junker, Holger Jon Moeller, Birgitte Sandfeld-Paulsen, Pieter de Heer, Luit Penninga, Philip Blach Rossen, Anders Krarup-Hansen, Ninna Aggerholm-Pedersen

    Published 2022-11-01
    Get full text
    Article

Search Tools: